These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 9669425

  • 1. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [Abstract] [Full Text] [Related]

  • 2. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [Abstract] [Full Text] [Related]

  • 3. The alternative pathway C3 convertase and glomerular deposits.
    West CD, McAdams AJ.
    Pediatr Nephrol; 1999 Jun; 13(5):448-53. PubMed ID: 10412868
    [Abstract] [Full Text] [Related]

  • 4. Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1995 Jun; 25(6):853-61. PubMed ID: 7771481
    [Abstract] [Full Text] [Related]

  • 5. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
    West CD, Witte DP, McAdams AJ.
    Am J Kidney Dis; 2001 Jun; 37(6):1120-30. PubMed ID: 11382679
    [Abstract] [Full Text] [Related]

  • 6. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R, Pulieri P, Piras R, Iatropoulos P, Valoti E, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2018 Jun; 9():2329. PubMed ID: 30487789
    [Abstract] [Full Text] [Related]

  • 7. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
    Varade WS, Forristal J, West CD.
    Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
    [Abstract] [Full Text] [Related]

  • 8. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD.
    Am J Kidney Dis; 1987 Feb; 9(2):115-20. PubMed ID: 3826060
    [Abstract] [Full Text] [Related]

  • 9. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.
    J Pediatr; 1990 May; 116(5):S98-102. PubMed ID: 2329415
    [Abstract] [Full Text] [Related]

  • 10. [Ultrastructural study on membranoproliferative glomerulonephritis with special reference to subepithelial deposits].
    Sato H.
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):973-83. PubMed ID: 2263028
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 12. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 13. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

  • 14. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
    Meyers KE, Strife CF, Witzleben C, Kaplan BS.
    Am J Kidney Dis; 1996 Dec; 28(6):804-10. PubMed ID: 8957031
    [Abstract] [Full Text] [Related]

  • 15. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM, van de Kar NCAJ, van Kraaij SAW, Sarlea SA, Gracchi V, Engels FAPT, Dorresteijn EM, van der Deure J, Duineveld C, Wetzels JFM, van den Heuvel LPWJ, Volokhina EB.
    Front Immunol; 2021 Dec; 12():715704. PubMed ID: 34456924
    [Abstract] [Full Text] [Related]

  • 16. Nephritic factors predispose to chronic glomerulonephritis.
    West CD.
    Am J Kidney Dis; 1994 Dec; 24(6):956-63. PubMed ID: 7985676
    [Abstract] [Full Text] [Related]

  • 17. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 18. Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.
    West CD, Bissler JJ.
    Pediatr Nephrol; 2008 Oct; 23(10):1867-76. PubMed ID: 18594868
    [Abstract] [Full Text] [Related]

  • 19. A hemolytic method for the measurement of nephritic factor.
    West CD.
    J Immunol Methods; 2008 Jun 01; 335(1-2):1-7. PubMed ID: 18410942
    [Abstract] [Full Text] [Related]

  • 20. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Jun 01; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.